Clinical outcomes and patient satisfaction following Laser Blended Vision for presbyopia correction using MeL 90 platform - LBV

Research Foundation Nethradhama Eye Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1.Subjects medically suitable for LASIK,
•2. Presbyopic with corrected distant visual acuity(CDVA) no worse than 20/25 in either eye
•3. Tolerance of at least -0.75 D anisometropia
•4. Myopic patients with spherical equivalent (SE) refraction -8.50 D in both eyes
•5. Hyperopic patients with SE upto +5.75 D in both eyes
•6. Willing to accept a slight difference in vision between both eyes 8. Willing to use prescription corrective lenses to enhance vision to do precision tasks(reading small prints, needlework)
•7. Soft contact lens discontinued for minimum 1 week and Rigid Gas Permeable contact lens discontinued for minimum 3 week
•8.Ability to understand and willingness to sign informed consent and participate in follow up visits

•1.Eyes with dense amblyopia with BSCVA < 6/12
•2.Evidence of ocular diseases like severe meibomian gland diseases, herpetic keratitis, uvietis, glaucoma.
•3.Visually significant cataract, retinal diseases like retinal dystrophies or diabetic retinopathy.
•4.Corneal pathologies like corneal dystrophies , keratoconus, H/o corneal trauma or surgery within flap zone
•5.Dry eye status-Schirmer’s I value less than 10 mm
•6.Long term ocular medication like ß blockers.
•7. Patients on systemic medication likely to affect wound healing like corticosteroids or antimetabolites.
•8.H/o immunocompromised state or pregnancy or nursing mothers .
•9.Patients with unrealistic expectations.

发起方

Research Foundation Nethradhama Eye Hospital